Deteriorated outcome of recent patients with acute liver failure and late‐onset hepatic failure caused by infection with hepatitis A virus: A subanalysis of patients seen between 1998 and 2015 and enrolled in nationwide surveys in Japan
- 7 April 2019
- journal article
- research article
- Published by Wiley in Hepatology Research
- Vol. 49 (8) , 844-852
Abstract
Aim: A nationwide survey of acute liver failure (ALF) and late‐onset hepatic failure (LOHF) has revealed that the outcomes of recent patients whose diseases were caused by infection with hepatitis A virus (HAV) have worsened, compared with those of previously reported patients. The factors associated with this deterioration were evaluated.Methods: A total of 83 patients with HAV infection seen between 1998 and 2015 were enrolled. All the patients had a prothrombin time–international normalized ratio of 1.5 or more and hepatic encephalopathy of grade 2 or more severe. The demographic and clinical features of 45 patients seen prior to 2003 (cohort 1) and 38 patients seen during 2004 and thereafter (cohort 2) were compared.Results: Three and four patients in cohort 1 and cohort 2, respectively, received liver transplantations; the survival rates among the remaining patients were 56% for cohort 2 and 79% for cohort 1 (P < 0.05). The mean age (±standard deviation) of the patients was higher in cohort 2 than in cohort 1 (58 ± 11 vs. 48 ± 13 years; P < 0.01). The percentages of patients with underlying metabolic diseases were 22% in cohort 1 and 61% in cohort 2 (P < 0.01). Diabetic mellitus was more common among deceased patients than among rescued patients (29% vs. 8%; P < 0.05) among patients who did not receive liver transplantations, and a multivariate analysis revealed that patient age and disease type were significantly and independently associated with the outcome.Conclusion: The outcomes of recent patients with ALF or LOHF caused by HAV infection have recently worsened mainly because of an increase in underlying metabolic diseases as a consequence of aging.Keywords
Funding Information
- Japan Agency for Medical Research and Development (18fk0210043h0001)
This publication has 25 references indexed in Scilit:
- Nationwide survey for acute liver failure and late-onset hepatic failure in JapanJournal of Gastroenterology, 2017
- Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapiesJournal of Gastroenterology, 2016
- Etiology and prognosis of fulminant hepatitis and late‐onset hepatic failure in Japan: Summary of the annual nationwide survey between 2004 and 2009Hepatology Research, 2013
- Acute liver failure in Japan: definition, classification, and prediction of the outcomeJournal of Gastroenterology, 2012
- Diagnostic criteria of acute liver failure: A report by the Intractable Hepato‐Biliary Diseases Study Group of JapanHepatology Research, 2011
- Fulminant hepatitis and late onset hepatic failure in JapanHepatology Research, 2008
- AASLD position paperHepatology, 2005
- Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national surveyHepatology Research, 2004
- Classification of acute liver failureThe Lancet, 1993
- Fulminant Hepatic FailureNew England Journal of Medicine, 1968